Cleveland Clinic bivalent article getting high traffic

A half-dozen Substacks, over two thousand tweets within 4 days of release. No factchecks or mainstream media articles as yet.

It is my impression that the Cleveland Clinic bivalent (non)efficacy article, which was as large as the original Pfizer vaccine trials in 2020 with over fifty thousand participants, is getting significant attention. For the moment, this appears to be restricted to non-legacy media. It will be interesting to see when it surfaces in the general population, and how it will be presented. Presumably the preprint will be factchecked by Reuters or Associated Press at some point over coming days.

This article appears likely to generate as much attention as the Mansanguan article from Thailand, which identified high rates of post-2nd Pfizer vaccine myocarditis and cardiac abnormalities in adolescents, back in August 2022.